Advanced search
Publication Cover
Journal of Biopharmaceutical Statistics Volume 30, 2020 - Issue 2
Submit an article Journal homepage
192
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Approximate confidence limit for the reference scaled bioequivalence with a parallel design

Jason J.Z. Liaoa Biostatistics and Research Decision Sciences, Merck & Co., Inc, North Wales, PA, USACorrespondence[email protected]
&
Yifang Lib Early Development Biostatistics, Novartis Pharmaceuticals Corporation, Cambridge, MA, USA
Pages 231-243 | Received 27 Mar 2018, Accepted 11 Aug 2019, Published online: 27 Aug 2019

References

  • Burdick, R. K., N. Thomas, and A. Cheng. 2017. Statistical considerations in demonstrating CMC analytical similarity for a biosimilar product. Statistics in Biopharmaceutical Research 9 (3):pages 249–257. doi:10.1080/19466315.2017.1280412.
  • Chow, S.-C., J. Shao, and H. Wang. 2003. In vitro bioequivalence testing. Statistics in Medicine 22:55–68. doi:10.1002/(ISSN)1097-0258.
  • Davit, B. M. et al. 2012. Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration. AAPS Journal 14:915–924. doi:10.1208/s12248-012-9406-x.
  • Dong, X., Y. Bian, Y. Tsong, and T. Wang. 2017. Exact test-based approach for equivalence test with parameter margin. Journal of Biopharmaceutical Statistics 27 (2):317–330. doi:10.1080/10543406.2016.1265546.
  • Food and Drug Administration (FDA). 2001. Guidance for industry: Statistical approaches to establishing bioequivalence. U.S. Department of Health and Human Services, Washington, D.C.
  • Food and Drug Administration (FDA). 2011. Draft guidance for industry: Bioequivalence recommendation for progesterone oral capsules. U.S. Department of Health and Human Services, Washington, D.C.
  • Haidar, S. H. et al. 2007. Bioequivalence approaches for highly viable drugs and drug products. Pharmaceutical Research 25:237–241. doi:10.1007/s11095-007-9434-x.
  • Haidar, S. H. et.al. 2008. Evaluation of scaling approach for the bioequivalence of highly variable drugs. The AAPS Journal 10:450–454. doi:10.1208/s12248-008-9053-4.
  • Howe, W. G. 1974. Approximate confidence limits on the mean of X+Y where X and Y are two tabled independent random variables. Journal of the American Statistical Association 69 (347):789–794.
  • Hyslop, T., F. Hsuan, and D. J. Holder. 2000. A small sample confidence interval approach to assess individual bioequivalence. Statistics in Medicine 19:2885–2897.
  • Liao, J. J. Z., and J. F. Heyse. 2011. Biosimilarity for follow-on biologics. Statistics in Biopharmaceuticals Research 3 (3):445–455. doi:10.1198/sbr.2011.10036.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.